Using highly sensitive culturomics, TMP1 was found to be enriched in stool samples from RCC and melanoma anti‐PD1 recipients experiencing longer OS, providing (to our knowledge) the first clinical evidence supporting this phenomenon [113]. The gene discussed is PDCD1; the disease is melanoma.